Minimise Occupational Risks, Optimise Industrial Hygiene Standards & Foster a Safety-Minded Culture Across R&D & Manufacturing Facilities
As the biopharmaceutical industry rapidly evolves, robust Environment, Health & Safety (EHS) practices are more critical than ever. Safely managing novel drug modalities, reducing occupational exposure, and building a proactive safety culture are essential for compliance, risk reduction, and operational excellence.
The EHS for Biopharma Summit Europe is the first event of its kind, bringing together EHS leaders from big pharma, biotech, and CDMOs to share practical strategies and benchmark progress across lab and GMP environments.
Across three content-rich days, attendees will explore risk assessment, biosafety, hazardous waste, cultural transformation, regulatory compliance, and emerging technologies such as AI to build the strategic insights needed to build a future-ready EHS function across R&D and manufacturing sites
Join 80+ global EHS leaders from AstraZeneca, Vertex, Ipsen, Novo Nordisk, and more as they exchange insights, drive innovation, and shape the future of EHS in biopharma towards safer, smarter, and more sustainable science.
Certificate of Attendance
Participation in this safety initiative qualifies you for a certificate of attendance, which can be used toward your Continuing Professional Development (CPD) requirements.
*Please check with your relevant organisations to confirm eligibility.






Attending Companies Include








